143 related articles for article (PubMed ID: 12605094)
1. Dopamine D3 receptor gene Ser9Gly variant and schizophrenia: association study and meta-analysis.
Jönsson EG; Flyckt L; Burgert E; Crocq MA; Forslund K; Mattila-Evenden M; Rylander G; Asberg M; Nimgaonkar VL; Edman G; Bjerkenstedt L; Wiesel FA; Sedvall GC
Psychiatr Genet; 2003 Mar; 13(1):1-12. PubMed ID: 12605094
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between the dopamine D3 gene polymorphism (Ser9Gly) and schizophrenia in Japanese populations: evidence from a case-control study and meta-analysis.
Utsunomiya K; Shinkai T; De Luca V; Hwang R; Sakata S; Fukunaka Y; Chen HI; Ohmori O; Nakamura J
Neurosci Lett; 2008 Oct; 444(2):161-5. PubMed ID: 18703116
[TBL] [Abstract][Full Text] [Related]
3. The dopamine D3 receptor (DRD3) Ser9Gly polymorphism and schizophrenia: a haplotype relative risk study and association with clozapine response.
Malhotra AK; Goldman D; Buchanan RW; Rooney W; Clifton A; Kosmidis MH; Breier A; Pickar D
Mol Psychiatry; 1998 Jan; 3(1):72-5. PubMed ID: 9491816
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia.
Jönsson EG; Kaiser R; Brockmöller J; Nimgaonkar VL; Crocq MA
Psychiatr Genet; 2004 Mar; 14(1):9-12. PubMed ID: 15091310
[No Abstract] [Full Text] [Related]
5. European Multicentre Association Study of Schizophrenia: a study of the DRD2 Ser311Cys and DRD3 Ser9Gly polymorphisms.
Spurlock G; Williams J; McGuffin P; Aschauer HN; Lenzinger E; Fuchs K; Sieghart WC; Meszaros K; Fathi N; Laurent C; Mallet J; Macciardi F; Pedrini S; Gill M; Hawi Z; Gibson S; Jazin EE; Yang HT; Adolfsson R; Pato CN; Dourado AM; Owen MJ
Am J Med Genet; 1998 Feb; 81(1):24-8. PubMed ID: 9514583
[TBL] [Abstract][Full Text] [Related]
6. Association of the DRD2 CA
Xu S; Liu J; Yang X; Qian Y; Xiao Q
J Neurol Sci; 2017 Jan; 372():433-438. PubMed ID: 27817855
[TBL] [Abstract][Full Text] [Related]
7. Further evidence of no association between Ser9Gly polymorphism of dopamine D3 receptor gene and schizophrenia.
Chen CH; Liu MY; Wei FC; Koong FJ; Hwu HG; Hsiao KJ
Am J Med Genet; 1997 Feb; 74(1):40-3. PubMed ID: 9034004
[TBL] [Abstract][Full Text] [Related]
8. The Ser9Gly polymorphism of the dopamine D3 receptor gene and risk of schizophrenia: an association study and a large meta-analysis.
Ma G; He Z; Fang W; Tang W; Huang K; Li Z; He G; Xu Y; Feng G; Zheng T; Zhou J; He L; Shi Y
Schizophr Res; 2008 Apr; 101(1-3):26-35. PubMed ID: 18295456
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in the dopamine-2 receptor (DRD2), dopamine-3 receptor (DRD3), and dopamine transporter (SLC6A3) genes in schizophrenia: Data from an association study.
Sáiz PA; García-Portilla MP; Arango C; Morales B; Arias B; Corcoran P; Fernández JM; Alvarez V; Coto E; Bascarán MT; Bousoño M; Fañanas L; Bobes J
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):26-31. PubMed ID: 19766158
[TBL] [Abstract][Full Text] [Related]
10. Genetic association between the dopamine D3 receptor gene polymorphism (Ser9Gly) and tardive dyskinesia in patients with schizophrenia: a reevaluation in East Asian populations.
Utsunomiya K; Shinkai T; Sakata S; Yamada K; Chen HI; De Luca V; Hwang R; Ohmori O; Nakamura J
Neurosci Lett; 2012 Jan; 507(1):52-6. PubMed ID: 22172931
[TBL] [Abstract][Full Text] [Related]
11. Mutation and association analysis of the 5' region of the dopamine D3 receptor gene in schizophrenia patients: identification of the Ala38Thr polymorphism and suggested association between DRD3 haplotypes and schizophrenia.
Ishiguro H; Okuyama Y; Toru M; Arinami T
Mol Psychiatry; 2000 Jul; 5(4):433-8. PubMed ID: 10889555
[TBL] [Abstract][Full Text] [Related]
12. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism.
Lerer B; Segman RH; Fangerau H; Daly AK; Basile VS; Cavallaro R; Aschauer HN; McCreadie RG; Ohlraun S; Ferrier N; Masellis M; Verga M; Scharfetter J; Rietschel M; Lovlie R; Levy UH; Meltzer HY; Kennedy JL; Steen VM; Macciardi F
Neuropsychopharmacology; 2002 Jul; 27(1):105-19. PubMed ID: 12062911
[TBL] [Abstract][Full Text] [Related]
13. Meta-analysis of the influence of DRD3 Ser9Gly variant on susceptibility for essential tremor.
Mao X; Wang T; Liu M; Chang X; Li N; Gu Y; Zhao D; Liao Q; Peng R
J Clin Neurosci; 2013 Dec; 20(12):1644-9. PubMed ID: 24054403
[TBL] [Abstract][Full Text] [Related]
14. Dopamine D3 receptor Ser9Gly polymorphism and risperidone response.
Lane HY; Hsu SK; Liu YC; Chang YC; Huang CH; Chang WH
J Clin Psychopharmacol; 2005 Feb; 25(1):6-11. PubMed ID: 15643094
[TBL] [Abstract][Full Text] [Related]
15. Association between dopamine D3 receptor gene polymorphisms and schizophrenia in an isolate population.
Staddon S; Arranz MJ; Mancama D; Perez-Nievas F; Arrizabalaga I; Anney R; Buckland P; Elkin A; Osborne S; Munro J; Mata I; Kerwin RW
Schizophr Res; 2005 Feb; 73(1):49-54. PubMed ID: 15567076
[TBL] [Abstract][Full Text] [Related]
16. A cluster of single nucleotide polymorphisms in the 5'-leader of the human dopamine D3 receptor gene (DRD3) and its relationship to schizophrenia.
Sivagnanasundaram S; Morris AG; Gaitonde EJ; McKenna PJ; Mollon JD; Hunt DM
Neurosci Lett; 2000 Jan; 279(1):13-6. PubMed ID: 10670776
[TBL] [Abstract][Full Text] [Related]
17. Association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and tardive dyskinesia in Chinese schizophrenic patients.
Liao DL; Yeh YC; Chen HM; Chen H; Hong CJ; Tsai SJ
Neuropsychobiology; 2001; 44(2):95-8. PubMed ID: 11490179
[TBL] [Abstract][Full Text] [Related]
18. [D3 dopamine receptor gene Ser9Gly polymorphism in Russian patients with schizophrenia].
Aksenova MG; Shestakova IuN; Abramova LI; Frolova LP; Shemiakina TK; Lezheĭko TV; Lavrushina OM; Barkhatova AN; Nosikov VV; Golimbet VE
Zh Nevrol Psikhiatr Im S S Korsakova; 2004; 104(10):57-61. PubMed ID: 15553379
[TBL] [Abstract][Full Text] [Related]
19. No association between the Ser9Gly polymorphism of the dopamine D3 receptor gene and schizophrenia in a Spanish sample.
Lorenzo CV; Baca-Garcia E; Hernandez MD; Martin CB; Perez-Rodriguez MM; Saiz-Gonzalez MD; Fernández P; Gutierrez FJ; Saiz-Ruiz J; Piqueras JF; de Rivera JL; de Leon J
Am J Med Genet B Neuropsychiatr Genet; 2007 Apr; 144B(3):344-6. PubMed ID: 17171662
[TBL] [Abstract][Full Text] [Related]
20. Dopamine D3 receptor (DRD3) gene polymorphism is associated with the intensity of eye movement disturbances in schizophrenic patients and healthy subjects.
Rybakowski JK; Borkowska A; Czerski PM; Hauser J
Mol Psychiatry; 2001 Nov; 6(6):718-24. PubMed ID: 11673801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
